SCHEMBL8871973

SCHEMBL8871973

O=[N+]([O-])c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.83
ABCG2 Q9UNQ0 1/20 0.67
ERBB2 P04626 2/20 0.66
MEN1 O00255 2/20 0.66
MAPT P10636 2/20 0.66
HTT P42858 2/20 0.66
KMT2A Q03164 2/20 0.66
KDM4E B2RXH2 1/20 0.66
NPC1 O15118 1/20 0.66
PRNP P04156 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP3A4 P08684 1/20 0.66
CYP2D6 P10635 1/20 0.66
CYP2C9 P11712 1/20 0.66
CYP2C19 P33261 1/20 0.66
ALK Q9UM73 1/20 0.65
FADS1 O60427 1/20 0.63
LCK P06239 1/20 0.62
ALDH1A1 P00352 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18349251 0.87 EGFR (0.77) EGFRABCG2ERBB2MEN1MAPT
SCHEMBL1192454 0.86 EGFR (1.00) EGFRABCG2MEN1MAPTHTT
SCHEMBL8871504 0.86 EGFR (0.76) EGFRABCG2ERBB2MAPTHTT
SCHEMBL4587413 0.86 EGFR (0.83) EGFRABCG2MEN1MAPTHTT
SCHEMBL30552991 0.86 EGFR (1.00) EGFRABCG2ERBB2ALK
SCHEMBL3244621 0.86 EGFR (1.00) EGFRABCG2ERBB2ALK
SCHEMBL28805920 0.85 EGFR (0.73) EGFRERBB2
SCHEMBL31299935 0.84 EGFR (0.68) EGFRERBB2MEN1MAPTHTT
SCHEMBL5422743 0.84 EGFR (0.68) EGFRERBB2MEN1MAPTHTT
SCHEMBL4355658 0.83 EGFR (1.00) EGFRERBB2MEN1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616582-A Use as anticancer agents; e.g. gefitinib ZENECA LIMITED (GB) 1997-04-01 US disclosed
EP-0566226-B1 Quinazoline derivatives ZENECA LTD (GB) 1995-11-08 EP disclosed
US-5457105-A anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) ZENECA LIMITED (GB) 1995-10-10 US disclosed
EP-0566226-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1993-10-20 EP disclosed